Teratogenesis [teratogeneze]

topical
27
Terms

teratogenese

Persistent link   https://www.medvik.cz/link/D064793
Definition

The formation of CONGENITAL ABNORMALITIES.

DUI
D064793 MeSH Browser
CUI
M0584204
History note
2014
Public note
2014

Allowable subheadings

DE
drug effects 7
ES
ethics
GE
genetics
IM
immunology
PH
physiology
RE
radiation effects

C Diseases
C01 Infections 2 026
C04 Neoplasms 12 774
C05 Musculoskeletal Diseases 1 120
C06 Digestive System Diseases 673
C07 Stomatognathic Diseases 117
C08 Respiratory Tract Diseases 2 218
C09 Otorhinolaryngologic Diseases 678
C10 Nervous System Diseases 1 878
C11 Eye Diseases 1 489
C12 Urogenital Diseases 6
C14 Cardiovascular Diseases 10 507
C15 Hemic and Lymphatic Diseases 91
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities 439
C17 Skin and Connective Tissue Diseases 32
C18 Nutritional and Metabolic Diseases 172
C19 Endocrine System Diseases 886
C20 Immune System Diseases 746
C21 Disorders of Environmental Origin 22
C22 Animal Diseases 442
C23 Pathological Conditions, Signs and Symptoms 451
C23.550 Pathologic Processes 195
C23.550.035 Acantholysis 10
C23.550.073 Arrhythmias, Cardiac 2 789
C23.550.081 Ascites 333
C23.550.113 Atrial Remodeling 13
C23.550.145 Azotemia 5
C23.550.161 Cardiotoxicity 138
C23.550.177 Channelopathies 13
C23.550.210 Chromosome Aberrations 1 574
C23.550.260 Death 1 396
C23.550.274 Dehydration 401
C23.550.277 Delayed Graft Function 24
C23.550.288 Disease 1 709
C23.550.291 Disease Attributes 1 208
C23.550.308 Dysbiosis 103
C23.550.325 Emphysema 89
C23.550.340 Extravasation of Diagnostic and Therapeutic Materials 36
C23.550.347 Femoracetabular Impingement 27
C23.550.355 Fibrosis 362
C23.550.359 Frailty 118
C23.550.362 Genomic Instability 87
C23.550.369 Gliosis 37
C23.550.382 Granuloma 236
C23.550.384 Granulomatosis, Orofacial 6
C23.550.393 Growth Disorders 634
C23.550.403 Hemolysis 382
C23.550.414 Hemorrhage 2 284
C23.550.421 Hyperammonemia 31
C23.550.425 Hyperamylasemia 5
C23.550.429 Hyperbilirubinemia 184
C23.550.444 Hyperplasia 338
C23.550.449 Hyperuricemia 222
C23.550.455 Hypovolemia 87
C23.550.470 Inflammation 3 455
C23.550.505 Intraoperative Complications 714
C23.550.513 Ischemia 1 730
C23.550.522 Leukoaraiosis 4
C23.550.526 Leukocytosis 98
C23.550.537 Lithiasis 87
C23.550.543 Long Term Adverse Effects 7
C23.550.548 Malacoplakia 4
C23.550.568 Menstruation Disturbances 353
C23.550.589 Metaplasia 97
C23.550.695 Muscle Weakness 224
C23.550.706 Myotoxicity 1
C23.550.717 Necrosis 834
C23.550.722 Neointima 8
C23.550.727 Neoplastic Processes 130
C23.550.737 Nerve Degeneration 166
C23.550.744 Ochronosis 42
C23.550.751 Ossification, Heterotopic 139
C23.550.753 Ototoxicity 10
C23.550.755 Pigmentation Disorders 132
C23.550.759 Polydipsia 17
C23.550.767 Postoperative Complications 7 052
C23.550.770 Protein Aggregation, Pathological 15
C23.550.773 Respiratory Aspiration 78
C23.550.794 Retropneumoperitoneum 14
C23.550.823 Sclerosis 84
C23.550.835 Shock 409
C23.550.863 Teratogenesis 27
C23.550.877 Toxic Optic Neuropathy 1
C23.550.891 Ulcer 201
C23.550.918 Vascular Remodeling 29
C23.550.945 Yang Deficiency 9
C23.550.972 Yin Deficiency 9
C24 Occupational Diseases 3 880
C25 Chemically-Induced Disorders 30
C26 Wounds and Injuries 1 918

Add